Dali Pharmaceutical Co. Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 229.385 million compared to CNY 306.943 million a year ago. Operating income was CNY 15.131 million compared to CNY 4.112 million a year ago. Net income was CNY 14.719 million compared to CNY 5.406 million a year ago. Basic earnings per share from continuing operations was CNY 0.09 compared to CNY 0.03 a year ago.